Generics reduce costs and increase access

2016-09-21 Generics reduce costs for both patients and payers and increase patient’s access to medicines, according to a report by the Germany-based Institute for Healthcare and… Read More »

Use of generics in cardiovascular diseases

2016-09-19 Researchers from Italy and the US carried out a meta-analysis with the aim of comparing the efficacy and adverse events, either serious or mild/moderate, of… Read More »

Non-biological complex drug concept: experiences with iron sucrose and low molecular weight heparin

2015-08-25 When the patent of a classical small molecule drug expires, generics may be marketed if their therapeutic equivalence to the originator drug has been established.… Read More »

Canada’s generics are too expensive

2015-08-21 The same generics cost more in Canada than they do in similarly developed countries. In response to this, the premiers of each Canadian province recently… Read More »

Extrapolation of indications in biosimilars: epoetin

2015-08-19 Despite a stringent approval process, acceptance of biosimilars in the medical community continues to be low, and especially in extrapolated* indications. Members of the European… Read More »

Use of biosimilars in rheumatology

2015-08-17 In order to issue a position statement on the use of biosimilars in rheumatic diseases, the Sociedade Portuguesa de Reumatologia (Portuguese Society of Rheumatology) carried out… Read More »

Irish pharmacists’ perceptions and attitudes towards generics

2015-08-13 In June 2013, new legislation came into effect in Ireland – the Health (Pricing and Supply of Medical Goods) Act 2013 – that introduced generics… Read More »

US biosimilar uptake in the light of Obamacare

2015-08-11 A literature review by researchers at Tufts University in the US concludes that market uptake of biosimilars in the US will depend on regulatory policies,… Read More »

Generics losing out to brand-name drugs in Croatia

2015-08-07 A combination of weak national guidelines and powerful marketing by the pharmaceutical industry has led to a rise in brand-name over generics prescriptions for psychopharmaceuticals… Read More »

Comparison of biosimilar filgrastim versus other G-CSF formulations after autologous stem cell transplantation

2015-08-05 Introduction Only limited data have been so far published about the use of biosimilar filgrastim in haematologic recovery after autologous stem cell transplantation (ASCT). Despite… Read More »

Page 7 of 49 1 ... « Previous5 6 7 8 9 Next »... 49
Go Back Print